跳至主要内容
临床试验/CTRI/2024/10/075675
CTRI/2024/10/075675尚未招募不适用

A Single Arm Clinical Study To Evaluate The Role Of Jalaukavacharan For Kandu And Daha In Vranagranthi (Keloid).

Dr. Pragati Krushnarao Ghuse1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年11月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
To study the effect of leech application in keloid

研究概览

简要总结

Title- A SINGLE ARM CLINICAL STUDY TO EVALUATE THE ROLE OF JALAUKAVACHARAN FOR KANDU AND DAHA IN VRANAGRANTHI (KELOID).

Null Hypothesis : H0    Jalaukavacharan is not effective in vranagranthi(keloid).

Alternative Hypothesis : H1     Jalaukavacharan is effective in vranagranthi(keloid).

Study design -Single arm open label clinical trial

Inclusion Criteria:

1)Patient of vranagranthi with daha and kandu

2)Age group 18-60years.

3)Patients with written consent.

4)vranagranthi from all over the body except face

  1. Patient indicated with jalaukavacharan

6)Patients with familial pedigree for developing vranagranthi

[2] Exclusion Criteria:

  1. vrana granthi over vital areas.

2)Patient with uncontrolled Diabetes mellitus and hypertention.

3)Patient with bleeding disorder

4)Pregnancy

5)Patient with long term use of systemic corticosteroid , systemic chemotherapy or immunosuppresive drugs.

6)Patient with allergy to leeches.

7)Patient on anticoagulant medication.

Sample size- Total 30

Diagnosed patients of vranagranthi from OPD and IPD of Ayurvedic rugnalaya and camps in the periphery of parent rugnalaya and  research center will be taken as sample.

Study group-Jalaukavacharan

Total duration of drug administration will be 21 days.The mode of drug administration will be by local route.

Follow up - follow up will be on 7th, 14th, 21st, 28th day.

Result- Result will be drawn as per assesment criteria & statistical analysis

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1.Patient of vranagranthi with daha and kandu 2.Age group 18-60years.
  • 3.Patients with written consent.
  • 4.vranagranthi from all over the body except face 5.Patient indicated with jalaukavacharan 6.Patients with familial pedigree for developing vranagranthi.

排除标准

  • 1.vrana granthi over vital areas.
  • 2.Patient with uncontrolled Diabetes mellitus and hypertention.
  • 3.Patient with bleeding disorder 4.Pregnancy 5.Patient with long term use of systemic corticosteroid , systemic chemotherapy or immunosuppresive drugs.
  • 6.Patient with allergy to leeches.
  • 7.Patient on anticoagulant medication.

结局指标

主要结局

To study the effect of leech application in keloid

时间窗: 21 days study with follow up on 7th,14th,21st and 28th day

次要结局

  • 1. To establish jalaukavacharan as an effective treatment modality in vranagranthi .(2. Literature review of vranagranthi from ayurvedic text.)

研究者

发起方
Dr. Pragati Krushnarao Ghuse
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Pragati Krushnarao Ghuse

MES Ayurved Mahavidyalaya

研究点 (1)

Loading locations...

相似试验